Cargando…
Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice
BACKGROUND: Pregnant women are at increased risk of thrombotic adverse events. Plasma derived immune globulin (IG) products, which are used in pregnancy for various indications, may contain procoagulant impurity activated coagulation factor XI (FXIa). Procoagulant IG products have been associated wi...
Autores principales: | Xu, Yanqun, Liang, Yideng, Parunov, Leonid, Despres, Daryl, Eckhaus, Michael, Scott, Dorothy, Ovanesov, Mikhail, Struble, Evi B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648396/ https://www.ncbi.nlm.nih.gov/pubmed/33292285 http://dx.doi.org/10.1186/s12959-020-00245-8 |
Ejemplares similares
-
Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation
por: Parunov, Leonid A., et al.
Publicado: (2023) -
Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays
por: Liang, Yideng, et al.
Publicado: (2020) -
Effect of pH on thrombin activity measured by calibrated automated thrombinography
por: Jackson, Joseph W., et al.
Publicado: (2020) -
Fluorescence artifact correction in the thrombin generation assay: Necessity for correction algorithms in procoagulant samples
por: Chang, William C., et al.
Publicado: (2021) -
Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets
por: Tegegn, Tseday Z., et al.
Publicado: (2016)